Images
Participants
Contact
Radio 5 (RNE) has broadcasted a report on a molecule developed by IRB Barcelona capable of crossing the barrier that protects the brain and transporting drugs inside. The breakthrough made by the Peptide and Protein Laboratory was recently published in Angewandte Chemie.
Roger Prades, first author of the article and who did his PhD in this lab, and Benjamí Oller, a PhD student in the same lab, explain how this shuttle works. The molecule opens the door to the development of new drugs for diseases that affect the central nervous system, in addition to giving a new opportunity to drugs previously discarded because they are unable reach the brain unaided.
Listen to the report on RNE (4:10 minutes, in Spanish)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
